Biotech startup developing tests and treatments for Alzheimer’s and Parkinson’s disease raises $52.9M University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million… Read More
Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to… Read More
To fight Alzheimer’s disease, Univ. of Washington researchers target plaque-causing proteins Researchers at the University of Washington have created a molecule that aims to stop the formation of protein clusters thought… Read More
